Clinical Trials Browser

Phase 2 × Neoplasms × romidepsin × Clear all

NCT00020202 2024-03-04

FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Genetic Diseases, Inborn, Small Cell Lung Carcinoma

NCT01353664 2019-11-25

A Rollover Study for Patients Who Participated in Other Romidepsin Protocols

Phase 2 Completed

19 enrolled 12 charts

Lymphoma, Neoplasms